Focused Wealth Management’s CVS Health CVS Stock Holding History

Focused Wealth Management’s Portfolio CVS Stock Details CVS Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2024 Q1	–	Sell	-1,636	Closed	-$129K	–	362
2023 Q4	$129K	Sell	1,636 -227	-12%	-$16.2K	0.02%	174
2023 Q3	$130K	Buy	1,863 +5	+0.3%	+$354	0.02%	170
2023 Q2	$128K	Sell	1,858 -83	-4%	-$5.91K	0.02%	176
2023 Q1	$144K	Sell	1,941 -72	-4%	-$6.04K	0.03%	167
2022 Q4	$188K	Sell	2,013 -145	-7%	-$14K	0.04%	145
2022 Q3	$206K	Buy	2,158 +3	+0.1%	+$297	0.04%	128
2022 Q2	$200K	Sell	2,155 -196	-8%	-$19.1K	0.04%	137
2022 Q1	$238K	Buy	2,351 +668	+40%	+$70.2K	0.04%	142
2021 Q4	$174K	Buy	1,683 +1	+0.1%	+$92	0.03%	189
2021 Q3	$143K	Buy	1,682 +191	+13%	+$16K	0.02%	223
2021 Q2	$124K	Buy	1,491 +1	+0.1%	+$82	0.02%	257
2021 Q1	$112K	Buy	1,490 +2	+0.1%	+$146	0.02%	260
2020 Q4	$102K	Sell	1,488 -522	-26%	-$34K	0.02%	262
2020 Q3	$117K	Buy	2,010 +5	+0.2%	+$311	0.03%	221
2020 Q2	$130K	Buy	2,005 +232	+13%	+$14.6K	0.03%	185
2020 Q1	$105K	Sell	1,773 -25	-1%	-$1.67K	0.03%	190
2019 Q4	$134K	Buy	1,798 +280	+18%	+$19.7K	0.03%	220
2019 Q3	$96K	Sell	1,518 -376	-20%	-$22.3K	0.03%	240
2019 Q2	$103K	Sell	1,894 -497	-21%	-$26.8K	0.03%	236
2019 Q1	$129K	Sell	2,391 -1,701	-42%	-$105K	0.04%	180
2018 Q4	$268K	Buy	4,092 +1,072	+35%	+$80K	0.09%	117
2018 Q3	$238K	Buy	3,020 +1,389	+85%	+$99.3K	0.08%	126
2018 Q2	$105K	Sell	1,631 -100	-6%	-$6.59K	0.04%	215
2018 Q1	$108K	Sell	1,731 -50	-3%	-$3.59K	0.03%	232
2017 Q4	$129K	Buy	1,781 +846	+90%	+$61.5K	0.04%	208
2017 Q3	$76K	Sell	935 -1,096	-54%	-$86.7K	0.03%	188
2017 Q2	$163K	Buy	2,031 +1,200	+144%	+$94.8K	0.06%	169
2017 Q1	$65K	Hold	831	–	–	0.03%	258
2016 Q4	$66K	Sell	831 -50	-6%	-$4.05K	0.03%	244
2016 Q3	$78K	Sell	881 -1,650	-65%	-$156K	0.03%	225
2016 Q2	$242K	Buy	2,531 +1,563	+161%	+$156K	0.11%	120
2016 Q1	$100K	Buy	968 +87	+10%	+$8.46K	0.05%	139
2015 Q4	$86K	Buy	881 +100	+13%	+$9.79K	0.05%	163
2015 Q3	$75K	Hold	781	–	–	0.05%	165
2015 Q2	$82K	Buy	781 +24	+3%	+$2.45K	0.05%	154
2015 Q1	$78K	Hold	757	–	–	0.05%	163
2014 Q4	$72K	Buy	757 +50	+7%	+$4.41K	0.05%	163
2014 Q3	$56K	Hold	707	–	–	0.04%	184
2014 Q2	$53K	Hold	707	–	–	0.04%	178
2014 Q1	$53K	Buy	707 +100	+16%	+$7.06K	0.04%	165
2013 Q4	$43K	Hold	607	–	–	0.04%	184
2013 Q3	$34K	Buy	+607	New	+$36.2K	0.03%	193

Other funds holding CVS

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return

Dodge & Cox San Francisco, California $182B AUM 14.68% 1-Year Est. Return

Capital International Investors Los Angeles, California $427B AUM 29.17% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

Focused Wealth Management's CVS Position: Q1 2024 in Review

Focused Wealth Management sold out of CVS Health (CVS) in Q1 2024, closing a stake of 1,636 shares — an estimated $129K sold.

Focused Wealth Management first reported a position in CVS in Q3 2013 and held it in 42 quarters. The position peaked at $268K in Q4 2018. 2,176 funds tracked by Wall St. Rank hold CVS as of Q1 2024.

Focused Wealth Management reported no remaining CVS Health position as of Q1 2024 after selling out during the quarter.
Focused Wealth Management sold 1,636 CVS Health shares in Q1 2024, an estimated $129K.
Focused Wealth Management first reported a position in CVS Health in Q3 2013 and held it in 42 quarters.
Focused Wealth Management's CVS Health position peaked at $268K in Q4 2018.
2,176 funds tracked by Wall St. Rank held CVS Health as of Q1 2024.

Based on Focused Wealth Management's 13F filing for Q1 2024, filed 8 May 2024.